Literature DB >> 24609795

Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI.

S Kul1, H Uyarel, O T Kucukdagli, M Turfan, M A Vatankulu, A Tasal, E Erdogan, E Asoglu, M Sahin, T S Guvenc, O Goktekin.   

Abstract

OBJECTIVE: Contrast-induced acute kidney injury (CI-AKI) is a common complication in patients with acute ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The Mehran risk score was defined originally in elective PCI and may be predictive of CI-AKI. The aim of the present study was to investigate whether the Zwolle score predicts CI-AKI in patients with acute STEMI undergoing primary PCI. PATIENTS AND METHODS: We analyzed the data of 314 consecutive patients (mean age 56.3 ± 11.4 years) with acute STEMI undergoing primary PCI. The study population was divided into two groups according to CI-AKI development. The Mehran score, Zwolle score, baseline characteristics, and in-hospital outcomes were recorded.
RESULTS: Patients with CI-AKI had higher Mehran and Zwolle scores. In a receiver operating characteristic (ROC) curve analysis, high area under the curve (AUC) values were determined for Zwolle and Mehran scores (0.85 and 0.79, respectively) for CI-AKI development. A Zwolle score greater than  2 predicted CI-AKI with a sensitivity of 76.3 % and a specificity of 75.4 %. A Mehran score greater than 5 predicted CI-AKI with a sensitivity of 71.1 % and a specificity of 73.6 %.
CONCLUSION: Zwolle score predicts CI-AKI slightly better than the Mehran score in patients with STEMI undergoing primary PCI. This simple score can be used at the catheterization laboratory for risk stratification for the development of CI-AKI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24609795     DOI: 10.1007/s00059-013-3957-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  29 in total

1.  Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction.

Authors:  Fabio A Sgura; Luca Bertelli; Daniel Monopoli; Chiara Leuzzi; Elisa Guerri; Ilaria Spartà; Luigi Politi; Alessandro Aprile; Andrea Amato; Rosario Rossi; Giuseppe Biondi-Zoccai; Giuseppe M Sangiorgi; Maria G Modena
Journal:  Circ Cardiovasc Interv       Date:  2010-10-05       Impact factor: 6.546

Review 2.  Pathophysiology of contrast-induced nephropathy.

Authors:  James Tumlin; Fulvio Stacul; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Peter A McCullough
Journal:  Am J Cardiol       Date:  2006-02-17       Impact factor: 2.778

3.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

Review 5.  Contrast-induced nephropathy in invasive cardiology.

Authors:  Tilman Perrin; Eric Descombes; Stéphane Cook
Journal:  Swiss Med Wkly       Date:  2012-06-19       Impact factor: 2.193

6.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.

Authors:  Carlo Briguori; Flavio Airoldi; Davide D'Andrea; Erminio Bonizzoni; Nuccia Morici; Amelia Focaccio; Iassen Michev; Matteo Montorfano; Mauro Carlino; John Cosgrave; Bruno Ricciardelli; Antonio Colombo
Journal:  Circulation       Date:  2007-02-19       Impact factor: 29.690

7.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

Review 8.  Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.

Authors:  Peter McCullough
Journal:  Catheter Cardiovasc Interv       Date:  2006-03       Impact factor: 2.692

9.  Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge.

Authors:  Giuseppe De Luca; Harry Suryapranata; Arnoud W J van 't Hof; Menko-Jan de Boer; Jan C A Hoorntje; Jan-Henk E Dambrink; A T Marcel Gosselink; Jan Paul Ottervanger; Felix Zijlstra
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.